Andrej Janež
#90,300
Most Influential Person Now
Slovenian diabetologist and diabetes researcher
Andrej Janež's AcademicInfluence.com Rankings
Andrej Janežphilosophy Degrees
Philosophy
#11628
World Rank
#16051
Historical Rank
Logic
#8429
World Rank
#10546
Historical Rank
Download Badge
Philosophy
Andrej Janež's Degrees
- Doctorate Medicine University of Ljubljana
- PhD Medical Sciences University of Ljubljana
Why Is Andrej Janež Influential?
(Suggest an Edit or Addition)According to Wikipedia, Andrej Janež is a Slovenian diabetologist and diabetes researcher. Janež is the Head of Department of Endocrinology, Diabetes and Metabolic Disease at University Medical Centre Ljubljana, Assistant Professor for Internal Medicine at the Medical University Ljubljana, Chairman of the Advances in Diabetes and Insulin Therapy conference, member of the advisory board for peroral antidiabetic therapy in Servier Pharma, member for Slovenia in the Diabetes Education Study Group at European Association for the Study of Diabetes, and member of the European advisory board for continuous glucose monitoring system in development for Lifescan.
Andrej Janež's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Molecular mechanisms of insulin resistance and associated diseases. (2007) (327)
- Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1-3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10). (2020) (156)
- Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin (2013) (120)
- Female rats do not exhibit free fatty acid-induced insulin resistance. (2002) (110)
- Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment. (2020) (89)
- Thiazolidinedione treatment prevents free fatty acid-induced insulin resistance in male wistar rats. (2001) (80)
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome (2015) (69)
- Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes (2020) (62)
- Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus (2018) (62)
- Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome (2015) (59)
- Self-monitoring of blood glucose in diabetes: from evidence to clinical reality in Central and Eastern Europe--recommendations from the international Central-Eastern European expert group. (2014) (59)
- Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome. (2008) (56)
- Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study. (2018) (55)
- Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study (2015) (54)
- Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial (2017) (51)
- NLRP3 Inflammasome Polymorphism and Macrovascular Complications in Type 2 Diabetes Patients (2015) (45)
- Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review (2020) (43)
- Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study (2015) (43)
- Adiponectin/leptin ratio and insulin resistance in pregnancy (2013) (38)
- Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome. (2008) (38)
- CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patients (2014) (38)
- Adipocytokines and Insulin Resistance across Various Degrees of Glucose Tolerance in Pregnancy (2012) (38)
- Phosphodiesterase 4 inhibition as a potential new therapeutic target in obese women with polycystic ovary syndrome. (2014) (34)
- Efficacy of CD34+ Stem Cell Therapy in Nonischemic Dilated Cardiomyopathy Is Absent in Patients With Diabetes but Preserved in Patients With Insulin Resistance (2016) (33)
- The osmotic shock-induced glucose transport pathway in 3T3-L1 adipocytes is mediated by gab-1 and requires Gab-1-associated phosphatidylinositol 3-kinase activity for full activation. (2000) (32)
- Assessment of insulin resistance in young women with polycystic ovary syndrome (2008) (32)
- Effects of liraglutide on obesity-associated functional hypogonadism in men (2019) (31)
- DPP4 INHIBITOR SITAGLIPTIN AS A POTENTIAL TREATMENT OPTION IN METFORMIN-INTOLERANT OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME: A PILOT RANDOMIZED STUDY. (2017) (30)
- A NEW CLINICAL PREDICTION CRITERION ACCURATELY DETERMINES A SUBSET OF PATIENTS WITH BILATERAL PRIMARY ALDOSTERONISM BEFORE ADRENAL VENOUS SAMPLING. (2016) (30)
- Metformin as an initial adjunct to low-dose liraglutide enhances the weight-decreasing potential of liraglutide in obese polycystic ovary syndrome: Randomized control study (2016) (30)
- In Vivo Experimental Study of Noninvasive Insulin Microinjection through Hollow Si Microneedle Array (2018) (29)
- Management of patients with diabetes and obesity in the COVID-19 era: Experiences and learnings from South and East Europe, the Middle East, and Africa (2020) (26)
- Insulinoma induced hypoglycemia in a type 2 diabetic patient. (2001) (26)
- The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective. (2019) (26)
- Skeletal-muscle-derived mesenchymal stem/stromal cells from patients with osteoarthritis show superior biological properties compared to bone-derived cells. (2019) (25)
- Comprehensive analysis of skeletal muscle- and bone-derived mesenchymal stem/stromal cells in patients with osteoarthritis and femoral neck fracture (2020) (23)
- Impact of Treatment with Rosiglitazone or Metformin on Biomarkers for Insulin Resistance and Metabolic Syndrome in Patients with Polycystic Ovary Syndrome (2007) (23)
- Add on DPP-4 inhibitor alogliptin alone or in combination with pioglitazone improved β-cell function and insulin sensitivity in metformin treated PCOS (2017) (22)
- Comparison of alterations in insulin signalling pathway in adipocytes from Type II diabetic pregnant women and women with gestational diabetes mellitus (2002) (22)
- Effect of metformin and rosiglitazone on lipid metabolism in HIV infected patients receiving protease inhibitor containing HAART. (2005) (21)
- Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia (2021) (21)
- Metformin and Insulin Resistance: A Review of the Underlying Mechanisms behind Changes in GLUT4-Mediated Glucose Transport (2022) (21)
- Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Prevented Weight Regain in Obese Women with Polycystic Ovary Syndrome Previously Treated with Liraglutide: A Pilot Randomized Study. (2017) (20)
- Atherosclerosis Development and Progression: The Role of Atherogenic Small, Dense LDL (2022) (20)
- Lipoproteins and Cardiovascular Disease: An Update on the Clinical Significance of Atherogenic Small, Dense LDL and New Therapeutical Options (2021) (18)
- The Role of Genetic Factors and Kidney and Liver Function in Glycemic Control in Type 2 Diabetes Patients on Long-Term Metformin and Sulphonylurea Cotreatment (2014) (17)
- Decreased androgen levels and improved menstrual pattern after angiotensin II receptor antagonist telmisartan treatment in four hypertensive patients with polycystic ovary syndrome: case series. (2007) (17)
- Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative Review (2022) (16)
- High level of clinical inertia in insulin initiation in type 2 diabetes across Central and South-Eastern Europe: insights from SITIP study (2019) (16)
- Improvement of arterial wall characteristics by the low-dose fluvastatin and valsartan combination in type 1 diabetes mellitus patients (2013) (16)
- Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier? (2018) (15)
- The Relationship between COVID-19 and Hypothalamic–Pituitary–Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess—The CAPISCO International Expert Panel (2022) (14)
- Effect of rosiglitazone and metformin on insulin resistance in patients infected with human immunodeficiency virus receiving highly active antiretroviral therapy containing protease inhibitor: randomized prospective controlled clinical trial. (2007) (14)
- Lipodystrophy and metabolic abnormalities in Slovenian HIV-infected patients (2004) (14)
- Adoption of the ADA/EASD guidelines in 10 Eastern and Southern European countries: physician survey and good clinical practice recommendations from an International Expert Panel. (2020) (14)
- SGLT2 inhibitors in T2D and associated comorbidities — differentiating within the class (2019) (13)
- Prevalence of Endocrine and Metabolic Comorbidities in a National Cohort of Patients with Craniopharyngioma (2020) (13)
- Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG) (2017) (13)
- Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review (2021) (13)
- Long-term efficacy of metformin in overweight-obese PCOS: longitudinal follow-up of retrospective cohort (2019) (13)
- Increased Exhaustion of the Subchondral Bone-Derived Mesenchymal Stem/ Stromal Cells in Primary Versus Dysplastic Osteoarthritis (2020) (12)
- Glucagon Like Peptide 1 Receptor Agonists in the Treatment of Obesity. (2021) (11)
- ACCEPTABILITY OF CONTINUOUS GLUCOSE MONITORING IN ELDERLY DIABETES PATIENTS USING MULTIPLE DAILY INSULIN INJECTIONS. (2019) (10)
- Characterization of skin penetration efficacy by Au-coated Si microneedle array electrode (2015) (10)
- The role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanism (2021) (10)
- Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs (2019) (10)
- Translating results from the cardiovascular outcomes trials with glucagon-like peptide-1 receptor agonists into clinical practice: Recommendations from a Eastern and Southern Europe diabetes expert group. (2022) (9)
- Post-COVID syndrome, inflammation, and diabetes (2022) (9)
- The prevalence and characteristics of non-functioning and autonomous cortisol secreting adrenal incidentaloma after patients’ stratification by body mass index and age (2020) (9)
- Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial (2019) (9)
- Hypoglycemia identified by a continuous glucose monitoring system in a second-trimester pregnant woman with insulinoma: a case report (2017) (8)
- Glucagon-Like Peptide 1 and Taste Perception: From Molecular Mechanisms to Potential Clinical Implications (2021) (8)
- Continuous Subcutaneous Insulin Infusion in Adult Type 1 Diabetes Mellitus: Data from a Registry at the University Medical Centre Ljubljana, Slovenia (2012) (8)
- Insulin-mediated cellular insulin resistance decreases osmotic shock-induced glucose transport in 3T3-L1 adipocytes. (2000) (8)
- Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health (2022) (8)
- Genetic Variability in Antioxidative and Inflammatory Pathways Modifies the Risk for PCOS and Influences Metabolic Profile of the Syndrome (2020) (8)
- Glucagon-like peptide-1, a matter of taste? (2020) (7)
- SGLT2 Inhibitors and the Clinical Implications of Associated Weight Loss in Type 2 Diabetes: A Narrative Review (2021) (7)
- Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study (2022) (7)
- Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes: Current Knowledge and Future Avenues (2021) (7)
- Endocrine disorders after heart transplantation: national cohort study (2020) (7)
- Interplay between Oxidative Stress and Chronic Inflammation in PCOS: The Role of Genetic Variability in PCOS Risk and Treatment Responses (2019) (7)
- Metformin: from mechanisms of action to advanced clinical use (2017) (7)
- Very low-dose fluvastatin-valsartan combination decreases parameters of inflammation and oxidative stress in patients with type 1 diabetes mellitus. (2017) (7)
- Increased Coagulation and Decreased Fibrinolysis as Measured with Overall Hemostatic Potential Are Dependent on BMI and Not Associated with PCOS. (2017) (6)
- An impaired glucagon-like peptide-1 response is associated with prediabetes in polycystic ovary syndrome with obesity (2019) (6)
- Uptake of new antidiabetic medicines in 11 European countries (2021) (6)
- Long-term improvement of arterial wall characteristics in patients with diabetes mellitus type 1 using cyclic, intermittent treatment with a low-dose fluvastatin and valsartan combination. (2015) (6)
- Management Strategies for Hyperglycemia Associated with the α-Selective PI3K Inhibitor Alpelisib for the Treatment of Breast Cancer (2022) (6)
- Hybrid Closed-Loop Systems for the Treatment of Type 1 Diabetes: A Collaborative, Expert Group Position Statement for Clinical Use in Central and Eastern Europe (2021) (6)
- Perspectives of Patients with Insulin-Treated Type 1 and Type 2 Diabetes on Hypoglycemia: Results of the HAT Observational Study in Central and Eastern European Countries (2018) (5)
- SLC6A4 5HTTLPR Polymorphism Affects Insulin Secretion in Patients with Polycystic Ovary Syndrome (2018) (5)
- Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future Perspectives (2022) (5)
- Low serum testosterone is associated with impaired graft function early after heart transplantation (2017) (5)
- The Dual Pandemics of COVID-19 and Obesity: Bidirectional Impact (2022) (4)
- SORCS1 polymorphism and insulin secretion in obese women with polycystic ovary syndrome (2016) (4)
- An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes (2022) (4)
- Genetic variation in GLP1 receptor is associated with interindividual differences in weight lowering potential of liraglutide in obese women with PCOS (2015) (4)
- Switching to denosumab or bisphosphonates after completion of teriparatide treatment in women with severe postmenopausal osteoporosis. (2021) (4)
- Accuracy Evaluation of the WaveForm Cascade CGM System vs. Dexcom G5 Sensors (2018) (3)
- Does intervention with GLP-1 receptor agonist semaglutide modulate perception of sweet taste in women with obesity: study protocol of a randomized, single-blinded, placebo-controlled clinical trial (2021) (3)
- Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti-Atherosclerotic Mechanisms of Action Study (SAMAS) (2022) (3)
- GLP-1 Receptor Agonist Liraglutide Increased IVF Pregnancy Rates in Obese Women with PCOS and Previous Poor Response to First-Line Reproductive Treatments (2018) (3)
- Clinical Applicability of Patient- and Clinician-Reported Outcome Tools in the Management of Patients with Acromegaly. (2022) (3)
- Insulinoma Causing Liver Metastases 15 Years after Initial Surgery, Accompanied by Glomerulonephritis (2012) (3)
- Common polymorphisms in antioxidant genes are associated with diabetic nephropathy in Type 2 diabetes patients. (2015) (3)
- Insulinoma in a patient with type 2 diabetes mellitus (2000) (3)
- Semaglutide reduces fat accumulation in the tongue: a randomized single-blind, pilot study. (2021) (3)
- Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease—Current Evidence (2022) (2)
- Potential New Pharmacological Approaches in Obese Women with Polycystic Ovary Syndrome (2017) (2)
- Semaglutide delays 4‐hour gastric emptying in women with polycystic ovary syndrome and obesity (2022) (2)
- The Real-Life Effectiveness and Care Patterns of Diabetes Management Study for Balkan Region (Slovenia, Croatia, Serbia, Bulgaria): A Multicenter, Observational, Cross-Sectional Study (2017) (2)
- Expert Opinion: A Call for Basal Insulin Titration in Patients with Type 2 Diabetes in Daily Practice: Southeast European Perspective (2021) (2)
- Epicardial Adipocyte-derived TNF-α Modulates Local Inflammation in Patients with Advanced Coronary Artery Disease. (2022) (2)
- Short term intervention with liraglutide and metformin increased fertility potential in a subset of obese PCOS proceeding IVF (2017) (2)
- Effects of metformin withdrawal after long and short term treatment in PCOS: observational longitudinal study (2021) (2)
- Comparison of different methods investigating functional and morphological markers of early atherogenesis in obese women with polycystic ovary syndrome. (2016) (2)
- Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance (2023) (2)
- Treatment of osteoporosis with teriparatide: The Slovenian experience (2021) (1)
- Comparison of plasma metanephrines in patients with cyanotic and acyanotic congenital heart disease (2022) (1)
- Natural history of nonfunctioning adrenal incidentalomas: a 10-year longitudinal follow-up study (2021) (1)
- INDIVIDUALIZATION OF CUSTOM COMPOUNDED HORMONE THERAPY IN A PATIENT WITH CHEMOTHERAPY INDUCED PREMATURE OVARIAN INSUFFICIENCY AND IMPAIRED LIVER FUNCTION – CASE REPORT (2019) (1)
- Glucose transporter 4 mRNA expression in subcutaneous adipose tissue of women with PCOS remains unchanged despite metformin withdrawal: is there a cellular metabolic treatment legacy effect? (2021) (1)
- Current and emerging drugs for the treatment of atherosclerosis: the evidence to date (2022) (1)
- Dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin improved beta cell function and prevented a conversion rate to MTG and DM2 in metformin intolerant PCOS with high metabolic risk (2017) (1)
- 1148-P: Antioxidative Effects of Empagliflozin and Metformin in Type 1 Diabetes Mellitus Patients (2020) (1)
- Benefits of insulin degludec/liraglutide are maintained even in patients discontinuing sulphonylureas or dipeptidyl peptidase‐4 inhibitors upon initiation of degludec/liraglutide therapy: A post hoc analysis of the DUAL II and DUAL IX trials (2019) (1)
- Associations between Periodontitis, COVID-19, and Cardiometabolic Complications: Molecular Mechanisms and Clinical Evidence (2022) (1)
- Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update (2023) (1)
- Metabolc aspects of polycystic ovary syndrome (2007) (1)
- Incretin System: New Pharmacological Target in Obese Women with Polycystic Ovary Syndrome (2018) (1)
- MON-220 Androstendione Affects Endometrial Gene Expression Profile During Window of Implantation in Obese Infertile Women with PCOS (2019) (1)
- The Endometrial Transcriptome of Metabolic and Inflammatory Pathways During the Window of Implantation Is Deranged in Infertile Obese Polycystic Ovarian Syndrome Women. (2022) (1)
- On the taxonomy, chorology and nomenclatura of Narcissus asturiensis (Jord.) Pugsley subsp. brevicoronatus (Pugsley) Uribe-Echebarría (Amaryllidaceae) and its location in the group asturiensis-minor. (2018) (0)
- Endocrine Profile of Heart Transplant Recipients in an Early Post-transplant Period (2018) (0)
- WEIGHT MANAGEMENT PROGRAM FOR PATIENTS WITH DIABETES MELLITUS TYPE 2 TREATED WITH ORLISTAT – OUR EXPERIENCES (2003) (0)
- Recommendations for self-monitoring of blood glucose in diabetes in Central and Eastern Europe (2014) (0)
- Weight response to GLP-1 receptor agonists: Why women do it better? (2022) (0)
- Metabolic Status Determines the Efficacy of CD34+ Stem Cell Therapy in Patients With Non-Ischemic Dilated Cardiomyopathy (2015) (0)
- SUN-221 Effects of Liraglutide on Obesity-Associated Functional Hypogonadism in Men: A Randomized, Testosterone Replacement Treatment-Controlled Study (2019) (0)
- Periprostatic paraganglioma causing occult Cushing’s syndrome (2020) (0)
- Improvement of beta-cell function with DPP-4 inhibitor alogliptin vs alogliptin in combination with pioglitazone as a potential treatment target in metformin treated PCOS with persistent high metabolic risk: randomized pilot study (2016) (0)
- Hypercoagulable overall haemostatic potential is not intrinsically associated with PCOS but worsens with increasing BMI (2015) (0)
- Semaglutide in Obesity: Unmet Needs in Men (2023) (0)
- TUMOR HYPOGLYCEMIA – UNDER-RECOGNIZED MEDICAL EMERGENCY (2008) (0)
- Impact of COVID-19 Pandemic on Disease Control Status and Quality of Life of Patients with Acromegaly (2022) (0)
- Clinical applicability of using SAGIT instrument and AcroQol in the management of patients with acromegaly (2022) (0)
- Impaired GLP-1 response predicts prediabetes in obese PCOS with adverse metabolic phenotype independent of BMI (2018) (0)
- Genetic variability in the cholecystokinin A receptor affects lipid profile and glucose tolerance in patients with polycystic ovary syndrome (2022) (0)
- PCOS in women with type 1 diabetes mellitus is not related to diabetes duration or insulin dose (2016) (0)
- EFFICACY OF CD34+ STEM CELL THERAPY IN NON-ISCHEMIC DILATED CARDIOMYOPATHY IS ABSENT IN PATIENTS WITH DIABETES BUT PRESERVED IN PATIENTS WITH INSULIN RESISTANCE (2015) (0)
- Semaglutide reduces fat accumulation in the tongue of obese women with polycystic ovary syndrome: A randomized, placebo-controlled prospective study (2021) (0)
- Author response for "Benefits of insulin degludec/liraglutide (IDegLira) are maintained even in patients discontinuing sulphonylurea or dipeptidyl peptidase‐4 inhibitor upon initiation of IDegLira therapy: a post hoc analysis of the DUAL II and DUAL IX trials" (2019) (0)
- Assessment of Eating Disorders and Eating Behavior to Improve Treatment Outcomes in Women with Polycystic Ovary Syndrome (2022) (0)
- Primary hyperparathyroidism: Differences in presentation between older and younger patients (2021) (0)
- Natural history of nonfunctioning adrenal incidentalomas: A 10-year longitudinal observational study (2021) (0)
- Effect of Full-mouth Disinfection Protocol on Glycaemic Control and Subgingival Microbiota in Patients with Type 1 and Type 2 Diabetes. (2021) (0)
- Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study (2015) (0)
- Author’s response to reviews Title: Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial Authors: (2017) (0)
- Diagnostic value of basal cortisol level to predict adrenal insufficiency in patients treated with glucocorticoids during COVID-19: a single centre observational cohort study (2022) (0)
- Metabolic abnormalities in adult population with spinal muscular atrophy (2023) (0)
- The maintenance of long-term weight loss after semaglutide withdrawal in obese women with PCOS treated with metformin: A 2-year observational study (2023) (0)
- The effect of metformin and liraglutide on markers of subclinical atherosclerosis in women with polycystic ovary syndrome (2015) (0)
- Impaired insulin signaling pathway in skeletal muscle from subjects with insulinoma (2000) (0)
- Comprehensive analysis of skeletal muscle- and bone-derived mesenchymal stem/stromal cells in patients with osteoarthritis and femoral neck fracture (2020) (0)
- Factors associated with degraded trabecular bone score in heart transplant recipients (2021) (0)
- Empagliflozin-Metformin Combination Has Antioxidative and Anti-Inflammatory Properties that Correlate with Vascular Protection in Adults with Type 1 Diabetes (2022) (0)
- Novel Pharmaceutical and Nutraceutical-Based Approaches for Cardiovascular Diseases Prevention Targeting Atherogenic Small Dense LDL (2022) (0)
- The efficacy of long-term metformin treatment in overweight and obese women with PCOS: A 10-year database study (2019) (0)
- Rare adverse event of treatment with somapacitan after switch from somatotropine (2023) (0)
- Comparison of incidence and characteristics of non-functioning and autonomous cortisol secreting adrenal incidentaloma across different BMI and age distribution (2020) (0)
- 2198-PUB: The Impact of Basal Insulin Initiation to Background Sulfonylurea Treatment on Hypoglycemia Occurrence: Evaluation of the Balkan Cohort of Dune Study (2020) (0)
- A rare metanephrine–predominant secretion phenotype of paraganglioma challenged an interpretation of imaging localization (2021) (0)
- Cellular insulin resistance decreases osmotic shock-induced glucose transport in 3T3-L1 adipocytes (2000) (0)
- Semaglutide alters tongue transcriptome along with the improvement of taste perception and increased brain activation in response to sweet tasting solution in obese women with PCOS (2023) (0)
- The Role of Physicians’ Digital Tools in Pharmacological Management of Type 2 Diabetes Mellitus (2022) (0)
- Association between low testosterone and graft dysfunction early after heart transplantation: results from cross-sectional study (2016) (0)
- 956-P: Patient-Reported Outcomes and Improved Glycemic Control with CGM in Well-Controlled Elderly Diabetes Patients (2019) (0)
- Trabecular bone score assessment in heart transplant recipients stratified by time after transplantation (2020) (0)
- Multiple prolactinomas in a young man with Kallman syndrome and familial hypocalciuric hypercalcemia (2022) (0)
- CYP2C9, KCNJ11 and ABCC8 polymorphisms and the response to sulphonylurea treatment in type 2 diabetes patients (2014) (0)
- Effects of Mindfulness-Based Therapy on Clinical Symptoms and DNA Methylation in Patients with Polycystic Ovary Syndrome and High Metabolic Risk (2023) (0)
- SARS-CoV-2 Omicron symptoms and adverse effects of GLP-1 RA therapy (2022) (0)
This paper list is powered by the following services:
Other Resources About Andrej Janež
What Schools Are Affiliated With Andrej Janež?
Andrej Janež is affiliated with the following schools:
